Published in J Biol Chem on March 01, 2016
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem (2001) 6.90
Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol (2005) 5.39
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res (2004) 4.00
Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem (1989) 3.52
Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J (1987) 2.82
The growing landscape of lysine acetylation links metabolism and cell signalling. Nat Rev Mol Cell Biol (2014) 2.71
Protein glycation, diabetes, and aging. Recent Prog Horm Res (2001) 2.51
Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem (1986) 2.36
Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab (2008) 2.21
Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J (2003) 2.15
Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes (2003) 1.99
Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem (1995) 1.76
Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest (1997) 1.73
Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci U S A (1994) 1.71
The autoxidation of glyceraldehyde and other simple monosaccharides under physiological conditions catalysed by buffer ions. Biochim Biophys Acta (1984) 1.71
Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid Med Cell Longev (2010) 1.66
The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur J Biochem (1993) 1.63
Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine. Free Radic Biol Med (2007) 1.56
The lens in diabetes. Eye (Lond) (1993) 1.31
Molecular basis of arterial stiffening: role of glycation - a mini-review. Gerontology (2012) 1.26
Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification. Diabetes Metab Res Rev (2004) 1.22
Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline. J Clin Invest (1992) 1.21
Lysine residue 199 of human serum albumin is modified by acetylsalicyclic acid. FEBS Lett (1976) 1.19
Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence. Biochem J (2002) 1.15
Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions. Studies with the model fructosamine, N epsilon-(1-deoxy-D-fructos-1-yl)hippuryl-lysine. Eur J Biochem (1992) 1.13
AGEs and diabetic retinopathy. Invest Ophthalmol Vis Sci (2010) 1.13
Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes. Metabolism (2003) 1.09
alpha-Hydroxyaldehydes, products of lipid peroxidation. Biochim Biophys Acta (1994) 1.05
Fluorophores from aging human articular cartilage. J Biochem (1991) 1.04
Proteomic profiling of nonenzymatically glycated proteins in human plasma and erythrocyte membranes. J Proteome Res (2008) 1.01
Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J Clin Invest (1997) 1.01
Formation of reactive intermediates from Amadori compounds under physiological conditions. Arch Biochem Biophys (1995) 0.95
Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody. J Biochem (2004) 0.94
Aminoacetone oxidase from goat liver. Formation of methylglyoxal from aminoacetone. J Biol Chem (1987) 0.94
Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects. J Proteome Res (2011) 0.93
Reaction of human albumin with aspirin in vitro: mass spectrometric identification of acetylated lysines 199, 402, 519, and 545. Biochem Pharmacol (2009) 0.89
Degradation of glucose: reinvestigation of reactive alpha-Dicarbonyl compounds. J Agric Food Chem (2009) 0.89
Molecular basis of maillard amide-advanced glycation end product (AGE) formation in vivo. J Biol Chem (2011) 0.88
Protein modification by a Maillard reaction intermediate methylglyoxal. Immunochemical detection of fluorescent 5-methylimidazolone derivatives in vivo. FEBS Lett (1997) 0.88
Amides are novel protein modifications formed by physiological sugars. J Biol Chem (2001) 0.88
Degradation of 1-deoxy-D-erythro-hexo-2,3-diulose in the presence of lysine leads to formation of carboxylic acid amides. J Agric Food Chem (2010) 0.84
Sensitive and site-specific identification of carboxymethylated and carboxyethylated peptides in tryptic digests of proteins and human plasma. J Proteome Res (2015) 0.82
Specific tandem mass spectrometric detection of AGE-modified arginine residues in peptides. J Mass Spectrom (2015) 0.82
Analysis of glycated and ascorbylated proteins by gas chromatography-mass spectrometry. J Agric Food Chem (2002) 0.82
Helical peptide models for protein glycation: proximity effects in catalysis of the Amadori rearrangement. Chem Biol (2001) 0.81
Creatine plays a direct role as a protein modifier in the formation of a novel advanced glycation end product. J Biochem (2002) 0.80
Glycation sites of human plasma proteins are affected to different extents by hyperglycemic conditions in type 2 diabetes mellitus. Anal Bioanal Chem (2014) 0.80
Comprehensive analysis of maillard protein modifications in human lenses: effect of age and cataract. Biochemistry (2015) 0.80
Oxidative degradation of N(ε)-fructosylamine-substituted peptides in heated aqueous systems. Amino Acids (2015) 0.79
Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis. Kidney Int (1995) 0.77
Characterisation of the influences of aspirin-acetylation and glycation on human plasma proteins. J Proteomics (2014) 0.77
Validation study to compare effects of processing protocols on measured N (ε)-(carboxymethyl)lysine and N (ε)-(carboxyethyl)lysine in blood. J Clin Biochem Nutr (2013) 0.77
Use of 13C labeling and NMR spectroscopy for the investigation of degradation pathways of Amadori compounds. Biol Pharm Bull (2005) 0.76
Fructose-induced N-terminal glycation of enkephalins and related peptides. J Pept Sci (2008) 0.76